Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth
出版年份 2018 全文链接
标题
Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth
作者
关键词
-
出版物
MOLECULES
Volume 23, Issue 8, Pages 2071
出版商
MDPI AG
发表日期
2018-08-20
DOI
10.3390/molecules23082071
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial
- (2018) Cheol Min Shin et al. CLINICAL NUTRITION
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- New windows open for immunotherapy in lung cancer
- (2018) Lizza Hendriks et al. NATURE
- The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint
- (2017) Qingshui Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Down-regulation of histone deacetylase 4, −5 and −6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin
- (2017) Yukiko Oya et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Adsorption of galloyl catechin aggregates significantly modulates membrane mechanics in the absence of biochemical cues
- (2017) Takahisa Matsuzaki et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Coinhibitory Pathways in Immunotherapy for Cancer
- (2016) Susanne H. Baumeister et al. Annual Review of Immunology
- Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells
- (2016) Melanie R. Power Coombs et al. CANCER LETTERS
- Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins
- (2016) Masami Suganuma et al. MOLECULES
- Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
- (2016) Wei Yang et al. NATURE
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
- (2015) Kristin J. Lastwika et al. CANCER RESEARCH
- Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds
- (2014) Hirota Fujiki et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Mechanism-based inhibition of cancer metastasis with (−)-epigallocatechin gallate
- (2013) Atsushi Takahashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- Regulating miRNA by Natural Agents as a New Strategy for Cancer Treatment
- (2013) Sajiv Sethi et al. CURRENT DRUG TARGETS
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- New cancer treatment strategy using combination of green tea catechins and anticancer drugs
- (2010) Masami Suganuma et al. CANCER SCIENCE
- Indoleamine 2,3-Dioxygenase, an Immunomodulatory Protein, Is Suppressed by (−)-Epigallocatechin-3-gallate via Blocking of γ-Interferon-Induced JAK-PKC-δ-STAT1 Signaling in Human Oral Cancer Cells
- (2009) Chieh-Wen Cheng et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Green Tea Extracts for the Prevention of Metachronous Colorectal Adenomas: A Pilot Study
- (2008) M. Shimizu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More